Pharmanovia A/S: Financial statements 2023
CVR: 32287824
Source: annual report 2023, Danish Business Authority
01/04/2022 – 31/03/2023
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 43,983,779 and a net result of DKK 26,130,781 compared with DKK -21,600,385 the year before. That is an increase of 1,181.9% compared with the year before. Equity in the 2023 report amounted to DKK 19,640,086. The solvency ratio was 14.4%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 43,983,779
- Profit/Loss
- DKK 26,130,781
- Equity
- DKK 19,640,086
- Total Assets
- DKK 136,728,200
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 44M | 26.1M | 19.6M | 15 |
| 2022 | - | 3.4M | -21.6M | -6.5M | 18 |
| 2021 | - | 15.2M | -2M | 15.1M | 15 |
| 2020 | - | 3.7M | -13.7M | 17.1M | 12 |
| 2019 | - | 10.6M | -5.9M | -19.9M | 12 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 6, 2023, James Sang Bum Lee is registered as director of Pharmanovia A/S.
As of October 6, 2023, Jesper Wilhelm Voss has stepped down as director of Pharmanovia A/S.
As of May 24, 2023, James Sang Bum Lee has joined the board of directors of Pharmanovia A/S.
As of May 24, 2023, Felipe Andres Florez Arango has left the board of directors of Pharmanovia A/S.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.